Baldi, Bruno Guedes; Amaral, Alexandre Franco; Colares, Phillipe de Figueiredo Braga; Kairalla, Ronaldo Adib 
; Oliveira, Martina Rodrigues de; Carvalho, Carlos Roberto Ribeiro De
Source: American journal of medical genetics part a. Unidade: FM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALDI, Bruno Guedes et al. COVID-19 and lymphangioleiomyomatosis.. [Carta]: experience at a reference center and the potential impact of the use ofmTORinhibitors. American journal of medical genetics part a. Hoboken: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/ajmg.a.61877. Acesso em: 29 maio 2024. , 2020APA
Baldi, B. G., Amaral, A. F., Colares, P. de F. B., Kairalla, R. A., Oliveira, M. R. de, & Carvalho, C. R. R. D. (2020). COVID-19 and lymphangioleiomyomatosis.. [Carta]: experience at a reference center and the potential impact of the use ofmTORinhibitors. American journal of medical genetics part a. Hoboken: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/ajmg.a.61877NLM
Baldi BG, Amaral AF, Colares P de FB, Kairalla RA, Oliveira MR de, Carvalho CRRD. COVID-19 and lymphangioleiomyomatosis.. [Carta]: experience at a reference center and the potential impact of the use ofmTORinhibitors [Internet]. American journal of medical genetics part a. 2020 ; 182( 12): 3068-3070.[citado 2024 maio 29 ] Available from: https://doi.org/10.1002/ajmg.a.61877Vancouver
Baldi BG, Amaral AF, Colares P de FB, Kairalla RA, Oliveira MR de, Carvalho CRRD. COVID-19 and lymphangioleiomyomatosis.. [Carta]: experience at a reference center and the potential impact of the use ofmTORinhibitors [Internet]. American journal of medical genetics part a. 2020 ; 182( 12): 3068-3070.[citado 2024 maio 29 ] Available from: https://doi.org/10.1002/ajmg.a.61877
